|
|
Gene Symbol |
MAPK14 |
|
Aliases |
CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA |
|
Entrez Gene ID |
|
|
Gene Name |
Mitogen-activated protein kinase 14 |
|
Chromosomal Location |
6p21.31 |
|
HGNC ID |
|
|
Summary |
The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. Four alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0006935 |
Biological process |
Chemotaxis |
TAS |
10706854 |
GO:0007165 |
Biological process |
Signal transduction |
TAS |
10706854 |
GO:0007166 |
Biological process |
Cell surface receptor signaling pathway |
TAS |
10706854 |
GO:0010468 |
Biological process |
Regulation of gene expression |
IBA |
21873635 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IGI |
24299952 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IMP |
25754930, 26649771 |
GO:0031281 |
Biological process |
Positive regulation of cyclase activity |
IMP |
22027397 |
GO:0035556 |
Biological process |
Intracellular signal transduction |
IBA |
21873635 |
GO:0035556 |
Biological process |
Intracellular signal transduction |
IDA |
10838079 |
GO:0035924 |
Biological process |
Cellular response to vascular endothelial growth factor stimulus |
IMP |
18440775 |
GO:0042770 |
Biological process |
Signal transduction in response to DNA damage |
IMP |
20160708 |
GO:0043536 |
Biological process |
Positive regulation of blood vessel endothelial cell migration |
IMP |
18440775 |
GO:0045648 |
Biological process |
Positive regulation of erythrocyte differentiation |
IMP |
23483889 |
GO:0048010 |
Biological process |
Vascular endothelial growth factor receptor signaling pathway |
IMP |
18440775 |
GO:0070935 |
Biological process |
3'-UTR-mediated mRNA stabilization |
TAS |
20932473 |
GO:0071222 |
Biological process |
Cellular response to lipopolysaccharide |
IDA |
23776175 |
GO:0071223 |
Biological process |
Cellular response to lipoteichoic acid |
IMP |
26649771 |
GO:0071310 |
Biological process |
Cellular response to organic substance |
IBA |
21873635 |
GO:0071479 |
Biological process |
Cellular response to ionizing radiation |
IMP |
20160708 |
GO:0090400 |
Biological process |
Stress-induced premature senescence |
IMP |
20160708 |
GO:0098586 |
Biological process |
Cellular response to virus |
IMP |
25754930 |
GO:1900015 |
Biological process |
Regulation of cytokine production involved in inflammatory response |
IDA |
15251176 |
GO:2000379 |
Biological process |
Positive regulation of reactive oxygen species metabolic process |
IMP |
20160708 |
GO:2001184 |
Biological process |
Positive regulation of interleukin-12 secretion |
IMP |
25754930 |
GO:0005634 |
Cellular component |
Nucleus |
IBA |
21873635 |
GO:0005737 |
Cellular component |
Cytoplasm |
IBA |
21873635 |
GO:0004707 |
Molecular function |
MAP kinase activity |
IBA |
21873635 |
GO:0004707 |
Molecular function |
MAP kinase activity |
IDA |
7997261, 10330143, 20932473 |
GO:0004708 |
Molecular function |
MAP kinase kinase activity |
TAS |
10706854 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
9792677, 10601328, 11238443, 16189514, 16751104, 17255097, 17255949, 17380123, 17380128, 18624398, 20347885, 20368287, 20871633, 20936779, 21283629, 21900206, 21908610, 21988832, 22521293, 23397142, 23455922, 23560844, 23602568, 25241761, 25852190, 26496610 |
GO:0019899 |
Molecular function |
Enzyme binding |
IPI |
23483889 |
GO:0019903 |
Molecular function |
Protein phosphatase binding |
IPI |
10391943, 21283629 |
GO:0048273 |
Molecular function |
Mitogen-activated protein kinase p38 binding |
IPI |
11035004 |
|
Protein Information |
|
Protein Name |
Mitogen-activated protein kinase 14, CSAID-binding protein, MAP kinase 14, MAP kinase Mxi2, MAP kinase p38 alpha, MAX-interacting protein 2, cytokine suppressive anti-inflammatory drug binding protein, mitogen-activated protein kinase p38 alpha, p38 MAP kinase, p38 mitogen activated protein kinase, p38alpha Exip, stress-activated protein kinase 2A |
|
Function |
|
|
UniProt |
|
|
PDB |
2OKR, 2ONL, 1A9U, 1BL6, 1BL7, 1BMK, 1DI9, 1IAN, 1KV1, 1KV2, 1M7Q, 1OUK, 1OUY, 1OVE, 1OZ1, 1R39, 1R3C, 1W7H, 1W82, 1W83, 1W84, 1WBN, 1WBO, 1WBS, 1WBT, 1WBV, 1WBW, 1WFC, 1YQJ, 1ZYJ, 1ZZ2, 1ZZL, 2BAJ, 2BAK, 2BAL, 2BAQ, 2FSL, 2FSM, 2FSO, 2FST, 2GFS, 2I0H, 2LGC, 2NPQ, 2QD9, 2RG5, 2RG6, 2Y8O, 2YIS, 2YIW, 2YIX, |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000284503 |
|
Q969S2 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Cardiomyopathy |
|
Diabetic Foot |
|
Myocardial Ischemia |
|
Myocardial Diseases |
|
Digestive System Diseases |
Cholestasis |
|
Endocrine System Diseases |
Diabetes Mellitus |
|
PCOS |
|
Neoplasms |
Myeloid Leukemia |
|
Liver Cancer |
|
Lung Cancer |
|
Nervous System Diseases |
Neuropathy |
|
Psychiatric/Brain disorders |
Mental Depression |
|
Schizophrenia |
|
Mood Disorders |
|
|
References |
|
|
Aydos Alp, Gurel Aykut, Oztemur Islakoglu Yasemin, Noyan Senem, Gokce Bagdagul, Ecemis Tolga, Kaya Cemil, Aksu Arif Tarik, Gur Dedeoglu Bala |
Biotechnology Institute, Ankara University, Ankara, Turkey.| Test Tube Babies Unit, HRS Women Hospital, Ankara, Turkey.| Biotechnology Institute, Ankara University, Ankara, Turkey.| Biotechnology Institute, Ankara University, Ankara, Turkey.| Test Tube Babies Unit, Medicana International Ankara Hospital, Ankara, Turkey.| Department of Gynecology and Obstetrics, Liv Hospital, Ankara, Turkey.| Department of Gynecology and Obstetrics, TOBB ETU Hospital, Ankara, Turkey.| Department of Gynecology and Obstetrics, HRS Women Hospital, Ankara, Turkey.| Biotechnology Institute, Ankara University, Ankara, Turkey. |
PLoS One. 2016 Dec 20;11(12):e0168875. doi: 10.1371/journal.pone.0168875. |
Abstract
Polycystic ovary syndrome (PCOS) is a metabolic and endocrine disorder which affects women of reproductive age with prevalence of 8-18%. The oocyte within the follicle is surrounded by cumulus cells (CCs), which connect with mural granulosa cells (MGCs) that are responsible for secreting steroid hormones. The main aim of this study is comparing gene expression profiles of MGCs and CCs in PCOS and control samples to identify PCOS-specific differentially expressed genes (DEGs). In this study, two microarray databases were searched for mRNA expression microarray studies performed with CCs and MGCs obtained from PCOS patients and control samples. Three independent studies were selected to be integrated with naive meta-analysis since raw meta-data from these studies were found to be highly correlated. DEGs in these somatic cells were identified for PCOS and control groups. This study enabled us to reveal dysregulation in MAPK (mitogen activated protein kinase), insulin and Wnt signaling pathways between CCs and MGCs in PCOS. The meta-analysis results together with qRT-PCR validations provide evidence that molecular signaling is dysregulated through MGCs and CCs in PCOS, which is important for follicle and oocyte maturation and may contribute to the pathogenesis of the syndrome. |
|
|
|